Anmeldung erfolgt in Kürze...
Details werden geladen...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
SAN CARLOS, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ('Iovance' or the 'Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ('TIL”) therapies for patients with cancer, today announced that on July 16, 2026 (the 'Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 139,930 shares of Iovance’s common stock to seventeen new, non-executive employees.
Ähnliche Seiten
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/20/tmt-newswire/globenewswire/iovance-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2369296
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/monte-rosa-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2357297Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/equillium-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2357300Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/tenaya-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2384654ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/03/tmt-newswire/globenewswire/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2377821